|Posted on April 11, 2021 at 11:05 PM|
|Posted on March 17, 2021 at 7:30 PM|
Two Australian ophthalmologists are repurposing a common cholesterol-lowering drug into a topical ocular therapy for dry eye and blepharitis, which was given to a patient as part of an initial trial who went 90 seconds without blinking.
Dr Kenneth Ooi and Professor Stephanie Watson, from the University of Sydney’s Save Sight Institute, have completed a pilot study of their therapy called Atorvastatin, which they believe has the potential to treat ...Read Full Post »
|Posted on March 17, 2021 at 7:25 PM|
Patients suffering from dry eye disease symptoms have a lower quality of life compared to those without symptoms, a new study reports. The findings showed that patients with the condition reported negative effects on visual function, their ability to carry out daily activities and their work productivity.
Dry eye disease is a common condition and a frequent reason for patients to seek medical care. It can affect people of any age but is most prevalent in women and in older ...Read Full Post »
|Posted on March 17, 2021 at 7:20 PM|
Whether they are tears of pain or tears of joy, the truth about tears is that these tiny, salty droplets are essential for the nutrition, lubrication, and protection of our eyes.
But the precise biological mechanism behind how tears accomplish these feats was hazy. Part of the problem is there are few good ways to study crying in the lab, but a new study might offer a pathway to greater clarity. In a new paper published this week in the journal Cell Stem Cell, scientists des...Read Full Post »